Coloplast A/S (CLPBY)
| Previous Close | 12.36 |
| Open | 12.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 12.42 - 12.56 |
| 52 Week Range | 9.90 - 14.34 |
| Volume | |
| Avg. Volume | 94,430 |
| Market Cap | 28.265B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 38.06 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.30 (2.45%) |
| Ex-Dividend Date | May 17, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)
The event will take place on Thursday, 6 June 2024 at Coloplast’s HeadquartersHoltedam 3, 3050 Humlebaek, Denmarkfrom 11.30 - 18.00 CEST (Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2024 Meet the Management event.The event will be held in person at our headquarters in Humlebaek, Denmark, with the option to join us virtually for the plenary session.The purpose of the event is to provide participants with the opportunity to meet
- GlobeNewswire
Coloplast expands its Luja™ portfolio with next generation catheter for women
Luja Female Luja Female is an intermittent catheter that enables complete bladder emptying in one free flow, aiming to reduce the risk of urinary tract infections. The female intermittent catheter enables complete bladder emptying in one free flow1, aiming to reduce the risk of urinary tract infections2. Following the successful launch of Luja with Micro-hole Zone Technology, a next generation intermittent catheter for men, Coloplast is now launching Luja for women. “So far, we have received gre
- GlobeNewswire
Coloplast strengthens ostomy care portfolio with three significant product launches
Heylo Heylo is the world's first digital leakage notification system. SenSuraMio_Black SenSura Mio in black developed to provide more product choice for people living with a stoma. The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products. As part of our 2025 strategy, Strive25, we set an ambition to significantly raise the standard of care for our users and bring ne
